Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Xenetic Biosciences, Inc. (XBIO)

Pharmaceutical Preparations

https://www.xeneticbio.com

Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer.

945 CONCORD ST.
FRAMINGHAM, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/16/2012

Market Cap

5,320,383

Shares Outstanding

1,540,000

Weighted SO

1,540,684

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

RNAZ --.--%

LABP --.--%

NEXI --.--%

ONCR --.--%

ZVSA --.--%

IMMX --.--%

PHIO --.--%

ATNF --.--%

NAVB --.--%

Beta

2.3000

Last Div

0.0000

Range

2.78-5.97

Chg

0.3000

Avg Vol

9920

Mkt Cap

5320383

Exch

NASDAQ

Country

US

Phone

781 778 7720

DCF Diff

7.0245

DCF

-3.0745

Div Yield

0.0000

P/S

2.1110

EV Multiple

0.3950

P/FV

0.7139

Div Yield %

0.0000

P/E

-1.1319

PEG

-0.0286

Payout

0.0000

Current Ratio

5.0485

Quick Ratio

5.0485

Cash Ratio

4.5972

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

1.0000

Op Margin

-1.9871

Pretax Margin

-1.8633

Net Margin

-1.8633

Eff Tax Rate

0.0172

ROA

-0.5199

ROE

-0.5103

ROCE

-0.6726

NI/EBT

1.0000

EBT/EBIT

0.9377

EBIT/Rev

-1.9871

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-85.4330

CF/Debt

0.0000

Equity Multi

1.2132

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.2790

OCF/Share

-2.2242

FCF/Share

-2.2242

Cash/Share

4.7369

OCF/Sales

-1.3598

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.7139

P/B

0.7139

P/S

2.1110

P/E

-1.1319

P/FCF

-1.5524

P/OCF

-1.5511

P/CF

-1.5511

PEG

-0.0286

P/S

2.1110

EV Multiple

0.3950

P/FV

0.7139

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation